Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Aug 20;38:13. doi: 10.1186/s41232-018-0071-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 2 — Effects of linagliptin, ketoprofen, or Loxo treatment on LPS-induced IL-6 production after 24 h. Human U937 monocytes were treated with LPS and/or linagliptin, ketoprofen, or Loxo. IL-6 levels in the supernatants were determined via ELISA after 24 h of treatment. *P < 0.0001 vs. control; †P < 0.001 vs. LPS 1 μg/mL; ‡P < 0.0001 vs. LPS 1 μg/mL. Lina, linagliptin; Keto, ketoprofen